
October 23, 2023
RegMed Investors’ (RMi) pre-open: A risk-off mood is “ruling” markets
October 20, 2023
RegMed Investors (RMi) Closing Bell: cauterizing a wound after a portfolio whack, almost
October 20, 2023
RegMed Investors’ (RMi) pre-open: the sector is without pricing sustainability
October 19, 2023
RegMed Investors (RMi) Closing Bell: buyers, wherefore art thou?
October 19, 2023
RegMed Investors (RMi) Research Note: Beam Therapeutics (BEAM) reduces headcount
October 19, 2023
RegMed Investors’ (RMi) pre-open: sentiment share-shifts
October 18, 2023
RegMed Investors (RMi) Research Note: Ultragenyx Pharmaceutical (RARE) has priced its public offering at $30.00 per share of 8,33 M stock
October 18, 2023
RegMed Investors (RMi) Closing Bell: staring into the abyss after scrambling into safety
October 18, 2023
RegMed Investors’ (RMi) pre-open: Confidence perceived is not always value achieved!
October 17, 2023
RegMed Investors (RMi) Closing Bell: a lot of background noise
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors